David A. Siegel Avita Medical, Inc. Transaction History

Two Sigma Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$12.56 - $18.31 $335,352 - $488,876	-26,700 Reduced 68.99%	12,000 $192,000
Q4 2023 Feb 14, 2024	SELL	$9.29 - $14.57 $485,866 - $762,011	-52,300 Reduced 57.47%	38,700 $530,000
Q3 2023 Nov 14, 2023	SELL	$13.84 - $20.79 $326,624 - $490,644	-23,600 Reduced 20.59%	91,000 $1.33 Million
Q2 2023 Aug 14, 2023	BUY	$10.7 - $17.48 $604,550 - $987,620	56,500 Added 97.25%	114,600 $1.95 Million
Q1 2023 May 15, 2023	BUY	$6.45 - $14.48 $307,665 - $690,696	47,700 Added 458.65%	58,100 $811,000
Q4 2022 Feb 14, 2023	BUY	$4.53 - $7.55 $47,112 - $78,520	10,400 New	10,400 $68,000

6.01M

35.5K

38K

Ticker RCEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,030,900
Market Cap $217M
Description
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.